natgillin/translations-raw huggingface dataset:
Consideration should be given to replacing zidovudine in a combination anti-retroviral treatment (ART) regimen if this is already established.
Ako je već uspostavljen režim kombinirane antiretrovirusne terapije, treba razmotriti zamjenu zidovudina drugim lijekom.
- 12 vials of powder for solution for injection, 12 ampoules of solvent for parenteral use, 12 injection syringes, 24 injection needles and 12 cleansing swabs.
12 štrcaljki za injekciju, 24 igle za injekciju i 12 tupfera za čišćenje.
Standard haematologic tests, blood chemistry and a test of thyroid function must be conducted in all patients prior to initiating therapy.
U svih se bolesnika prije početka liječenja moraju provesti standardne hematološke i biokemijske pretrage kao i ispitivanje funkcije štitnjače.
Device body
Primatelji presatka organa
A positive predictive value of 50 % (52/104; Study 1) was observed for HCV/HIV co-infected patients receiving bitherapy.
Za bolesnike s istodobnom infekcijom HCV-om i HIV-om koji su primali dvojnu terapiju zabilježena je pozitivna prediktivna vrijednost od 50% (52/104; Ispitivanje 1).
*, injection site inflammation, fatigue, asthenia, irritability, chills, pyrexia, influenza like illness, pain
reakcija na mjestu injiciranja*, upala na mjestu injiciranja, umor, astenija, razdražljivost, zimica, pireksija, bolest nalik gripi, bol
ViraferonPeg 1.5 micrograms/kg
ViraferonPeg 1,5 mikrograma/kg
Ear pain
bol u uhu
You should use a different place each time you give yourself an injection.
Lijek trebate injicirati svaki puta na drugo mjesto.
8 cleansing swabs; - 12 pre-filled pens containing powder and solvent for solution for injection, 12 needles ("Push-On Needle"),
8 tupfera za čišćenje - 12 napunjenih brizgalica koje sadrže prašak i otapalo za otopinu za injekciju 12 igala (potisna igla)
Therefore, each vial contains an extra amount of solvent and ViraferonPeg powder to ensure delivery of the labeled dose in 0.5 ml of ViraferonPeg, solution for injection.
Stoga svaka bočica sadrži dodatnu količinu otapala i ViraferonPeg praška kako bi se osigurala primjena deklarirane doze u 0,5 ml ViraferonPeg otopine za injekciju.
120 micrograms/0.5 ml
120 mikrograma/0,5 ml
nd dose reduction of ViraferonPeg is to 0.5 µg/kg/week.
Ako je potrebno, drugo smanjenje doze lijeka ViraferonPeg je na 0,5 μg/kg na tjedan.
150 micrograms/0.5 ml
150 mikrograma/0,5 ml
Monotherapy with ViraferonPeg and bitherapy with ViraferonPeg and ribavirin Naïve patients
Monoterapija lijekom ViraferonPeg i dvojna terapija lijekom ViraferonPeg i ribavirinom Bolesnici koji prethodno nisu bili liječeni
- pain in joints and muscles, muscle and bone pain.
bol u kostima, mišićna slabost
ViraferonPeg 120 micrograms powder and solvent for solution for injection EU/1/00/132/016
ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/132/016
80 micrograms/0.5 ml
80 mikrograma/0,5 ml
8 cleansing swabs; - 12 pre-filled pens (CLEARCLICK) containing powder and solvent for solution for injection, 12 needles ("Push-On Needle"),
8 tupfera za čišćenje - 12 napunjenih brizgalica (CLEARCLICK) s praškom i otapalom za otopinu za injekciju 12 igala (potisna igla)
Vasculitis
vaskulitis
100 micrograms/0.5 ml
100 mikrograma/0,5 ml
Uncommon side effects (may affect up to 1 in 100 people): - painful or difficult urination, urinary frequency, the presence of excess protein in the urine, painful menstruation, - itchy anal area (pinworms or ascarids), inflammation of the lining membrane of the stomach and the intestines, inflamed gums, enlarged liver, - abnormal behaviour, emotional disorder, fear, nightmare, tremor, decreased sensitivity to touch, numbness or tingling feeling, pain radiating along the course of one or more nerves, drowsiness, - bleeding of the mucous membrane that lines the inner surface of the eyelids, itchy eyes, eye pain, blurred vision, intolerance to light, - low blood pressure, paleness, nasal discomfort, runny nose, wheezing, difficult breathing, chest pain or discomfort, - redness, swelling, pain of skin, shingles, skin sensitive to sunlight, rash with raised spotted lesions, skin discolouration, peeling of skin, shortening of muscle tissue, muscle twitching, facial pain, bruising.
Manje česte nuspojave (mogu se javiti u do 1 na 100 osoba): - bolno ili otežano mokrenje, učestalo mokrenje, prekomjerna količina bjelančevina u mokraći, bolna mjesečnica, - svrbež analnog područja (dječje gliste ili askaridi), upala želučane i crijevne sluznice, upala desni, povećana jetra, - neuobičajeno ponašanje, emocionalni poremećaj, strah, noćne more, nevoljno drhtanje, smanjena osjetljivost na dodir, utrnulost ili trnci, bol koja sijeva uzduž jednog ili više živaca, omamljenost, - krvarenje iz sluznice koja oblaže unutarnju površinu kapaka, svrbež očiju, bol u oku, zamagljen vid, nepodnošenje svjetla, - snižen krvni tlak, bljedilo, osjećaj nelagode u nosu, curenje nosa, piskanje pri disanju, otežano disanje, bol ili nelagoda u prsima, - crvenilo, oticanje, bol kože, herpes zoster, osjetljivost kože na sunčevu svjetlost, osip s točkastim uzdignućima, promjena boje kože, ljuštenje kože, skraćenje mišićnog tkiva, trzanje mišića, bol u licu, stvaranje modrica.
1 mcg/kg/week (4 weeks)
1 µg/kg na tjedan (4 tjedna)
Package inserts of theophylline should be referred to when co-administering with the product (ViraferonPeg)
Potrebno je pročitati uputu o lijeku za teofilin kada se primjenjuje istodobno s ovim lijekom (ViraferonPeg).
Tell your doctor or healthcare professional or the doctor or healthcare professional of the child you are caring for as soon as possible.
Ako primijenite više lijeka ViraferonPeg nego što ste trebali Što prije obavijestite o tome liječnika ili drugog zdravstvenog radnika, ili liječnika odnosno drugog zdravstvenog radnika djeteta o kojem skrbite.
ViraferonPeg contains sucrose
ViraferonPeg sadrži saharozu
ViraferonPeg 120 micrograms - vial of powder
ViraferonPeg 120 mikrograma - bočica s praškom
ViraferonPeg 80 micrograms - vial of powder
ViraferonPeg 80 mikrograma - bočica s praškom
Bitherapy and monotherapy
Dvojna terapija i monoterapija
ViraferonPeg 150 micrograms powder and solvent for solution for injection EU/1/00/132/021
ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/132/021
ViraferonPeg 80 micrograms powder and solvent for solution for injection EU/1/00/132/006
ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/132/006
Baseline Viral Load
serozna ablacija mrežnice
ViraferonPeg 150 micrograms - vial of powder
ViraferonPeg 150 mikrograma - bočica s praškom
Ophthalmologic disorders, including retinal haemorrhages, retinal exudates, serous retinal detachment, and retinal artery or vein occlusion have been reported in rare instances after treatment with alpha interferons (see section 4.8).
U rijetkim su slučajevima nakon liječenja alfa interferonima prijavljeni oftalmološki poremećaji, uključujući retinalna krvarenja, retinalne eksudate, seroznu ablaciju mrežnice te okluziju retinalne arterije ili vene (vidjeti dio 4.8).
9/l, and < 50 x 10
9/l i < 70 x 10
The reconstituted solution has a concentration of 120 micrograms in 0.5 ml.
Koncentracija rekonstituirane otopine je 120 mikrograma u 0,5 ml.
Haemoglobin
Hemoglobin
50 micrograms/0.5 ml
50 mikrograma/0,5 ml
ViraferonPeg 100 micrograms - vial of powder
ViraferonPeg 100 mikrograma - bočica s praškom
ViraferonPeg is supplied as: - 1 vial of powder for solution for injection and 1 ampoule of solvent for parenteral use; - 1 vial of powder for solution for injection, 1 ampoule of solvent for parenteral use, 1 injection syringe, 2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for parenteral use;
ViraferonPeg je dostupan u različitim veličinama pakiranja: - 1 bočica s praškom za otopinu za injekciju i 1 ampula s otapalom za injekciju; - 1 bočica s praškom za otopinu za injekciju, 1 ampula s otapalom za injekciju, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje; - 4 bočice s praškom za otopinu za injekciju i 4 ampule s otapalom za injekciju; - 4 bočice s praškom za otopinu za injekciju, 4 ampule s otapalom za injekciju, 4 štrcaljke za injekciju, 8 igala za injekciju i 4 tupfera za čišćenje; - 6 bočica s praškom za otopinu za injekciju i 6 ampula s otapalom za injekciju; - 12 bočica s praškom za otopinu za injekciju, 12 ampula s otapalom za injekciju, 12 štrcaljki za injekciju, 24 igle za injekciju i 12 tupfera za čišćenje.
ViraferonPeg 100 micrograms powder and solvent for solution for injection EU/1/00/132/011
ViraferonPeg 100 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/132/011
Respiratory, thoracic and mediastinal disorders Very common:
Poremećaji dišnog sustava, prsišta i sredoprsja Vrlo često:
The following instructions explain how to use the pre-filled pen to inject yourself.
Kako koristiti ViraferonPeg napunjenu brizgalicu Sljedeće upute objašnjavaju kako koristiti napunjenu brizgalicu da biste si dali injekciju.
ViraferonPeg 50 micrograms - vial of powder
ViraferonPeg 50 mikrograma - bočica s praškom
The reconstituted solution has a concentration of 120 micrograms/0.5 ml.
Koncentracija rekonstituirane otopine je 120 mikrograma/0,5 ml.
ViraferonPeg 50 micrograms powder and solvent for solution for injection EU/1/00/132/001
ViraferonPeg 50 mikrograma prašak i otapalo za otopinu za injekciju EU/1/00/132/001
Cutaneous sarcoidosis
kožna sarkoidoza
ViraferonPeg 80 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/132/035
ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/132/035
The reconstituted solution has a concentration of 150 micrograms/0.5 ml.
Koncentracija rekonstituirane otopine je 150 mikrograma/0,5 ml.
ViraferonPeg 150 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/132/047
ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/132/047
The reconstituted solution has a concentration of 150 micrograms in 0.5 ml.
Koncentracija rekonstituirane otopine je 150 mikrograma u 0,5 ml.
Interferon alfa-2b (3 MIU) + ribavirin (1,000/1,200 mg) p < 0.001 P 1.5 vs.
+ ribavirin (1000/1200 mg) p < 0,001 za P 1,5 u odnosu na I p = 0,0143 za P 1,5/R u odnosu na I/R
The reconstituted solution has a concentration of 80 micrograms in 0.5 ml.
Koncentracija rekonstituirane otopine je 80 mikrograma u 0,5 ml.
1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab 4 vials of powder, 4 ampoules of solvent
1 bočica s praškom, 1 ampula s otapalom, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje
Excipients: disodium phosphate, anhydrous; sodium dihydrogen phosphate dihydrate, sucrose and polysorbate 80.
Pomoćne tvari: natrijev hidrogenfosfat, bezvodni; natrijev dihidrogenfosfat dihidrat, saharoza i polisorbat 80.
The reconstituted solution has a concentration of 80 micrograms/0.5 ml.
Koncentracija rekonstituirane otopine je 80 mikrograma/0,5 ml.
Reminder: Please read the “Other medicines” section of the Package Leaflet for ribavirin before using it in combination with this medicine.
Podsjetnik: molimo pročitajte dio "Drugi lijekovi" u uputi o lijeku za ribavirin prije nego što ga uzmete u kombinaciji s ovim lijekom. - uzimate telbivudin.
Table 9 Sustained response rates with ViraferonPeg + ribavirin (by ribavirin dose, genotype and viral load)
Tablica 9 Stopa trajnog terapijskog odgovora kod kombinacije ViraferonPeg + ribavirin
Table 2 Monotherapy dosing 0.5 g/kg
Tablica 2 Doziranje u monoterapiji 0,5 µg/kg
One vial of powder contains 80 micrograms of peginterferon alfa-2b and provides 80 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Jedna bočica s praškom sadrži 80 mikrograma peginterferona alfa-2b i iz nje se dobije 80 mikrograma/0,5 ml peginterferona alfa-2b, kada se pripremi prema uputama.
Pen label - ViraferonPeg 150 micrograms powder and solvent for solution for injection in prefilled pen
Naljepnica brizgalice - ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
Carton 50 micrograms powder and solvent for solution for injection in pre-filled pen
Kutija 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
OTHER
IU
Disodium phosphate, anhydrous Sodium dihydrogen phosphate dihydrate Sucrose
Prašak natrijev hidrogenfosfat, bezvodni natrijev dihidrogenfosfat dihidrat saharoza polisorbat 80
Each pre-filled pen provides 80 micrograms/0.5 ml of solution when reconstituted as recommended.
Jednom napunjenom brizgalicom dobiva se 80 mikrograma/0,5 ml otopine, kada se pripremi prema uputama.
The reconstituted solution has a concentration of 100 micrograms in 0.5 ml.
Koncentracija rekonstituirane otopine je 100 mikrograma u 0,5 ml.
ViraferonPeg 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.
Dental and periodontal disorders, which may lead to loss of teeth, have been reported in patients receiving ViraferonPeg and ribavirin combination therapy.
U bolesnika koji su primali kombiniranu terapiju lijekom ViraferonPeg i ribavirinom prijavljene su bolesti zuba i parodonta koje mogu dovesti do gubitka zuba.
ViraferonPeg 50 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/132/031
ViraferonPeg 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/132/031
ViraferonPeg 120 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/132/043
ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/132/043
Pen label - ViraferonPeg 120 micrograms powder and solvent for solution for injection in prefilled pen
Naljepnica brizgalice - ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
Each pre-filled pen provides 120 micrograms/0.5 ml of solution when reconstituted as recommended.
Jednom napunjenom brizgalicom dobiva se 120 mikrograma/0,5 ml otopine, kada se pripremi prema uputama.
Carton 120 micrograms powder and solvent for solution for injection in pre-filled pen
Kutija 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
The reconstituted solution has a concentration of 100 micrograms/0.5 ml.
Koncentracija rekonstituirane otopine je 100 mikrograma/0,5 ml.
Do not exceed the recommended dosage, and take it for as long as prescribed.
Nemojte primjenjivati veću dozu od preporučene i uzimajte lijek onoliko dugo koliko Vam je propisano.
One vial of powder contains 120 micrograms of peginterferon alfa-2b and provides 120 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Jedna bočica s praškom sadrži 120 mikrograma peginterferona alfa-2b i iz nje se dobije 120 mikrograma/0,5 ml peginterferona alfa-2b, kada se pripremi prema uputama.
Carton 80 micrograms powder and solvent for solution for injection in pre-filled pen
Kutija 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
The reconstituted solution has a concentration of 50 micrograms in 0.5 ml.
Koncentracija rekonstituirane otopine je 50 mikrograma u 0,5 ml.
st dose reduction of ribavirin is to 12 mg/kg/day, 2
U djece i adolescenata prvo smanjenje doze ribavirina je na 12 mg/kg na dan, a drugo smanjenje doze ribavirina je na 8 mg/kg na dan.
Pen label - ViraferonPeg 50 micrograms powder and solvent for solution for injection in prefilled pen
Naljepnica brizgalice - ViraferonPeg 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
Drug hypersensitivity
preosjetljivost na lijek
Each pre-filled pen provides 150 micrograms/0.5 ml of solution when reconstituted as recommended.
Jednom napunjenom brizgalicom dobiva se 150 mikrograma/0,5 ml otopine, kada se pripremi prema uputama.
Bipolar disorders
bipolarni poremećaji
ViraferonPeg 150 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.
ViraferonPeg 50 micrograms powder and solvent for solution for injection ViraferonPeg 80 micrograms powder and solvent for solution for injection ViraferonPeg 100 micrograms powder and solvent for solution for injection ViraferonPeg 120 micrograms powder and solvent for solution for injection ViraferonPeg 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b
ViraferonPeg 50 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 100 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju peginterferon alfa-2b
Dissolution of powder is completed by agitating it gently.
Bočicu treba nježno protresti da se prašak potpuno otopi.
One vial of powder contains 50 micrograms of peginterferon alfa-2b and provides 50 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Jedna bočica s praškom sadrži 50 mikrograma peginterferona alfa-2b i iz nje se dobije 50 mikrograma/0,5 ml peginterferona alfa-2b, kada se pripremi prema uputama.
ViraferonPeg 100 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/132/039
ViraferonPeg 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici EU/1/00/132/039
Carton 150 micrograms powder and solvent for solution for injection in pre-filled pen
Kutija 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
The reconstituted solution has a concentration of 50 micrograms/0.5 ml.
Koncentracija rekonstituirane otopine je 50 mikrograma/0,5 ml.
Table 9 Sustained response rates with ViraferonPeg + ribavirin (by ribavirin dose, genotype and viral load) HCV Genotype
(prema dozi ribavirina, genotipu i virusnom opterećenju) HCV genotip
Eye pain
bol u oku
EU/1/00/132/011 (1 vial of powder, 1 ampoule of solvent) EU/1/00/132/012 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
EU/1/00/132/011 (1 bočica s praškom, 1 ampula s otapalom) EU/1/00/132/012 (1 bočica s praškom, 1 ampula s otapalom, 1 štrcaljka za injekciju, 2 igle za injekciju i 1 tupfer za čišćenje)
One vial of powder contains 100 micrograms of peginterferon alfa-2b and provides 100 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Jedna bočica s praškom sadrži 100 mikrograma peginterferona alfa-2b i iz nje se dobije 100 mikrograma/0,5 ml peginterferona alfa-2b, kada se pripremi prema uputama.
Wheezing, nasal discomfort, rhinorrhoea Gastrointestinal disorders Very common:
piskanje pri disanju, nelagoda u nosu, rinoreja Poremećaji probavnog sustava Vrlo često:
Each pre-filled pen provides 50 micrograms/0.5 ml of solution when reconstituted as recommended.
Jednom napunjenom brizgalicom dobiva se 50 mikrograma/0,5 ml otopine, kada se pripremi prema uputama.
ViraferonPeg 120 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju Svaka bočica mora se rekonstituirati sa 0,7 ml vode za injekcije za primjenu najviše 0,5 ml otopine.
One vial of powder contains 150 micrograms of peginterferon alfa-2b and provides 150 micrograms/0.5 ml of peginterferon alfa-2b when reconstituted as recommended.
Jedna bočica s praškom sadrži 150 mikrograma peginterferona alfa-2b i iz nje se dobije150 mikrograma/0,5 ml peginterferona alfa-2b, kada se pripremi prema uputama.
Each vial provides 80 micrograms/0.5 ml of solution when reconstituted as recommended.
Iz jedne bočice dobiva se 80 mikrograma/0,5 ml otopine, kada se pripremi prema uputama.
Amount of ViraferonPe g to administer (µg)
Količina lijeka ViraferonPeg koju treba primijeniti (µg)
Each pre-filled pen provides 100 micrograms/0.5 ml of solution when reconstituted as recommended.
Jednom napunjenom brizgalicom dobiva se 100 mikrograma/0,5 ml otopine, kada se pripremi prema uputama.
Pen label - ViraferonPeg 80 micrograms powder and solvent for solution for injection in prefilled pen
Naljepnica brizgalice - ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
ViraferonPeg is supplied as: - 1 pre-filled pen (CLEARCLICK) containing powder and solvent for solution for injection, 1 needle ("Push-On Needle"), 2 cleansing swabs; - 4 pre-filled pens (CLEARCLICK) containing powder and solvent for solution for injection, 4 needles ("Push-On Needle"),
ViraferonPeg je dostupan u pakiranjima koja sadrže: - 1 napunjenu brizgalicu (CLEARCLICK) s praškom i otapalom za otopinu za injekciju 1 iglu (potisna igla)
Carton 100 micrograms powder and solvent for solution for injection in pre-filled pen
Kutija 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici
EU/1/00/132/047 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/132/048 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/132/050 (12 pens, 12 injection needles and 24 cleansing swabs)
EU/1/00/132/047 (1 brizgalica, 1 igla za injekciju i 2 tupfera za čišćenje) EU/1/00/132/048 (4 brizgalice, 4 igle za injekciju i 8 tupfera za čišćenje) EU/1/00/132/050 (12 brizgalica, 12 igala za injekciju i 24 tupfera za čišćenje)
Co-administered Medicine
NAČIN PRIMJENE LIJEKA
ViraferonPeg 50 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 80 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 100 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 120 micrograms powder and solvent for solution for injection in pre-filled pen ViraferonPeg 150 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
ViraferonPeg 50 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici ViraferonPeg 100 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici peginterferon alfa-2b
ViraferonPeg 50 micrograms powder and solvent for solution for injection ViraferonPeg 80 micrograms powder and solvent for solution for injection ViraferonPeg 100 micrograms powder and solvent for solution for injection ViraferonPeg 120 micrograms powder and solvent for solution for injection ViraferonPeg 150 micrograms powder and solvent for solution for injection
ViraferonPeg 50 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 80 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 100 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 120 mikrograma prašak i otapalo za otopinu za injekciju ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju
Dyspnoea
Trombociti
Interferon alfa-2b (3 MIU) + ribavirin (1,000/1,200 mg)
ViraferonPeg (1,5 do 0,5 mikrograma/kg) + ribavirin (1000/1200 mg)
ViraferonPeg 150 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 150 micrograms of peginterferon alfa-2b measured on a protein basis.
ViraferonPeg 150 mikrograma prašak i otapalo za otopinu za injekciju u napunjenoj brizgalici Jedna napunjena brizgalica sadrži 150 mikrograma peginterferona alfa-2b, mjereno na bazi proteina.